Pyrazinamide and Lung adenocarcinoma - a phase IV clinical study of FDA data

Summary:

Lung adenocarcinoma is reported only by a few people who take Pyrazinamide.

The phase IV clinical study analyzes which people take Pyrazinamide and have Lung adenocarcinoma. It is created by eHealthMe based on reports of 8,874 people who have side effects while taking Pyrazinamide from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 03, 2023

8,874 people reported to have side effects when taking Pyrazinamide.
Among them, 2 people (0.02%) have Lung adenocarcinoma.

What is Pyrazinamide?

Pyrazinamide has active ingredients of pyrazinamide. It is often used in tuberculosis. eHealthMe is studying from 8,917 Pyrazinamide users for its effectiveness, alternative drugs and more.

What is Lung adenocarcinoma?

Lung adenocarcinoma (a form of non-small cell lung cancer) is found to be associated with 777 drugs and 385 conditions by eHealthMe.

Number of Pyrazinamide and Lung adenocarcinoma reports submitted per year:

Could Pyrazinamide cause Lung adenocarcinoma?

Gender of people who have Lung adenocarcinoma when taking Pyrazinamide *:

female: 100 %
male: 0.0 %

Age of people who have Lung adenocarcinoma when taking Pyrazinamide *:

Common drugs people take besides Pyrazinamide *:

Prednisone: 1 person, 50.00%
Potassium Chloride: 1 person, 50.00%
Perindopril Erbumine: 1 person, 50.00%
Metoprolol Tartrate: 1 person, 50.00%
Megestrol Acetate: 1 person, 50.00%
Loperamide Hydrochloride: 1 person, 50.00%
Isoniazid: 1 person, 50.00%
Ethambutol Hydrochloride: 1 person, 50.00%
Clopidogrel Bisulfate: 1 person, 50.00%
Cataflam: 1 person, 50.00%

Common side effects people have besides Lung adenocarcinoma *:

Hepatitis (inflammation of the liver): 1 person, 50.00%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 50.00%
Drug Resistance (reduction in effectiveness of a drug): 1 person, 50.00%

Common conditions people have *:

Post Gastric Surgery Syndrome: 1 person, 50.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 50.00%
Neuralgia (pain in one or more nerves): 1 person, 50.00%
Hypokalemia (low potassium): 1 person, 50.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 50.00%
High Blood Pressure: 1 person, 50.00%
Disseminated Tuberculosis: 1 person, 50.00%
Disbacteriosis (condition with microbial imbalances on or inside the body): 1 person, 50.00%
Diarrhea: 1 person, 50.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pyrazinamide and have Lung adenocarcinoma?

Check whether Lung adenocarcinoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Lung adenocarcinoma and when was it recovered:

Lung adenocarcinoma in Pyrazinamide

Expand to all the drugs that have ingredients of pyrazinamide:

Lung adenocarcinoma and drugs with ingredients of pyrazinamide

Alternative drugs to, pros and cons of Pyrazinamide:

Pyrazinamide (8,917 reports)

Common Pyrazinamide side effects:

Fever: 723 reports
Nausea and vomiting: 508 reports

Browse all side effects of Pyrazinamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Lung adenocarcinoma treatments and more:

Lung adenocarcinoma (18,239 reports)

COVID vaccines that are related to Lung adenocarcinoma:

Common drugs associated with Lung adenocarcinoma:

How the study uses the data?

The study uses data from the FDA. It is based on pyrazinamide (the active ingredients of Pyrazinamide) and Pyrazinamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.